DLB vs VRTX · P/E 28, rev $1.35B vs P/E 30, rev $12.00B
Dolby Laboratories (DLB) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Dolby Laboratories (DLB) is a specialty business services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DLB revenue for 2025-09-26 was $1.35B. Net income was $256.5M. Revenue was up 5.9% from 2024-09-27 to 2025-09-26. DLB currently screens at market cap $7.19B and trailing P/E 28.3.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DLB currently screens at market cap $7.19B and trailing P/E 28.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DLB and VRTX stock pages for the full models.
Not investment advice.